Mucosal barrier injury; new parameters and the role of microbiota
Promotie: dhr. M.J. van Vliet, 13.15 uur, Academiegebouw, Broerstraat 5, Groningen
Proefschrift: Mucosal barrier injury; new parameters and the role of microbiota
Promotor(s): prof.dr. W.A. Kamps
Faculteit: Medische Wetenschappen
Contact: via de persvoorlichters van het UMCG, tel. 050-361 2200, e-mail: voorlichting bvl.umcg.nl
Mucosal barrier injury; new parameters and the role of microbiota
There are no objective parameters reflecting Mucosal barrier injury (MBI) in children treated with chemotherapeutics. The questionnaires used to score the severity of MBI have never been validated. Several parameters, reflecting both inflammation and cell loss, were measured in the process of MBI. Plasma citrulline showed to be an objective and easily measurable parameter for MBI in children. Use of this parameter will simplify further research concerning MBI.
More news
-
02 June 2026
Nominees Ben Feringa Impact Award 2026 | Interviews
-
26 May 2026
Student teams compete with self-driving cars
-
26 May 2026
Babs Gons, new guest writer at the UG